Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Human Vaccines & Immunotherapeutics|July 19, 2013
Long-term survival and outcome of patients originally given Mycobacterium vaccae for metastatic malignant melanomaFerdinando C M Cananzi, Satvinder Mudan, Mary Dunne, et al.
Medical Oncology (Northwood, London, England)|September 15, 2014
Elevated platelet to lymphocyte ratio predicts poor prognosis after hepatectomy for liver-only colorectal metastases, and it is superior to neutrophil to lymphocyte ratio as an adverse prognostic factorKyriakos Neofytou, Elizabeth C Smyth, Alexandros Giakoustidis, et al.
Langenbeck'S Archives of Surgery|January 14, 2014
Prognostic factors for primary gastrointestinal stromal tumours: are they the same in the multidisciplinary treatment era?Ferdinando C M Cananzi, Bruno Lorenzi, Ajay Belgaumkar, et al.
World Journal of Surgical Oncology|March 24, 2016
Two cases of gallbladder metastasis from renal cell carcinoma and review of literatureMafalda Costa Neves, Kyriakos Neofytou, Alexandros Giakoustidis, et al.
Annals of Hepato-Biliary-Pancreatic Surgery|September 15, 2018
Identifying the role of neutrophil-to-lymphocyte ratio and platelets-to-lymphocyte ratio as prognostic markers in patients undergoing resection of pancreatic ductal adenocarcinomaAlexandros Giakoustidis, Kyriakos Neofytou, Mafalda Costa Neves, et al.
Annals of Surgical Oncology|March 17, 2015
The Preoperative Lymphocyte-to-Monocyte Ratio is Prognostic of Clinical Outcomes for Patients with Liver-Only Colorectal Metastases in the Neoadjuvant SettingKyriakos Neofytou, Elizabeth C Smyth, Alexandros Giakoustidis, et al.
World Journal of Surgical Oncology|November 27, 2014
Combined ultrasonic aspiration and saline-linked radiofrequency precoagulation: a step toward bloodless liver resection without the need of liver inflow occlusion: analysis of 313 consecutive patientsEvangelos Felekouras, Athanasios Petrou, Kyriakos Neofytou, et al.
Oncology Reports|October 25, 2024
Expression of EGFRvIII and its co‑expression with wild‑type EGFR, or putative cancer stem cell biomarkers CD44 or EpCAM are associated with poorer prognosis in patients with hepatocellular carcinomaOzlem Sherif, Said A Khelwatty, Izhar Bagwan, et al.
Oncology Reports|October 30, 2020
Synergistic activity of agents targeting growth factor receptors, CDKs and downstream signaling molecules in a panel of pancreatic cancer cell lines and the identification of antagonistic combinations: Implications for future clinical trials in pancreatic cancerTanzeel Khan, Alan M Seddon, Angus G Dalgleish, et al.
Biology of the Cell|June 6, 2013
Role of the eIF4E binding protein 4E-BP1 in regulation of the sensitivity of human pancreatic cancer cells to TRAIL and celastrol-induced apoptosisReka Chakravarthy, Michael J Clemens, Grisha Pirianov, et al.
Pageof 6